Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages

  Shen, Irving ^a   Giacomuzzi, Carmen ^a   Ungerleider, Ross M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; HUMAN; INFANT; MORBIDITY; NEWBORN; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

APROTININ; CARDIOPULMONARY BYPASS; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; INFANT; INFANT, NEWBORN; POSTOPERATIVE PERIOD; ULTRAFILTRATION;

EID: 0037314802     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04697-0     Document Type: Conference Paper

References (55)

1. Jaggers J, Shearer I, Ungerleider RM. Cardiopulmonary bypass in infants, and children. In: Gravlee GP, et al, eds. Cardiopulmonary bypass: principles and practice. Philadelphia: Lippincott, Williams & Wilkins, 2000:633-61.
2. Chen YF, Tsai WC, Lin CC, et al. Leukocytic depletion alternatives expression of neurotropic molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg 2000;123:218-24.
3. Guy YJ, DeVries AJ, Boonstra PW, Oeveren WV. Leukocytic depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996;112:494-500.
4. Englander R, Cardarelli MG. Efficacy of leukocytic filters in the bypass circuit for infants undergoing cardiac operations. Ann Thorac Surg 1995;60:533-5.
5. Lodge AJ, et al. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Sur 1999;117:515-22.
6. Bronicki RA, et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2000;69:1490-5.
7. Langley S, et al. Methylprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2000;17:279-86.
8. Schurr UP, et al. Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg 2001;72:1316-20.
9. Shum-Tim D, et al. Systemic steroid pretreatment improves cerebral protection after circulatory arrest. Ann Thorac Surg 2001;72:1465-72.
10. Cecere G, et al. A 10-year review of pediatric perfusion practice in North America. Perfusion 2002;17:83-9.
11. Aoki M, et al. Aprotonin enhances acute recovery of cerebreal metabolism after circulatory arrest. Circulation 1993;86(Suppl 1):182.
12. Kahn MMH, et al. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass. Ann Thorac Surg 1999;68:473-8.
13. Kirshborn PM, et al. pH-Stat cooling improves cerebral metabolic recovery after circulatory arrest in a piglet model of aorto-pulmonary collaterals. J Thorac Cardiovasc Sur 1996;111:147-57.
14. Mossinger H, Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotonin dosage. Ann Thorac Surg 1998;65(Suppl):S45-51.
15. Davies MJ, et al. Prospective, randomized, double-blind study of high-dose aprotonin in pediatric cardiac operation. Ann Thorac Surg 1997;63:467-503.
16. D'Errico CC, Pharmacoeconomics analysis in a pediatric population. Ann Thorac Surg 1998;65(Suppl):S52-5.
17. Davila RM, Rawles T, Mack MJ. Venoarterial air embolus: a complication of vacuum-assisted venous drainage. Ann Thorac Surg 2001;71:1369-71.
18. Wilcox TW, Mitchell SJ, Gorman D. Venous air in the bypass circuit: a source of arterial line emboi exacerbated by vacuum-assisted drainage. Ann Thorac Surg 1999;68:1285-9.
19. Wilcox TW. Vacuum-assisted venous drainage: to air or not to air, that is the question. Has the bubble burst? J Extra Corpor Technol 2002;34:24-8.
20. Rider SP, et al. Assisted venous drainage, venous air, and gaseous microemboli transmission into the arterial line. An in vitro study. J Extra Corpor Technol 1998;30:160-5.
21. Spiess BD, et al. Perioperative transfusion medicine, 1st ed. Baltimore: Williams & Wilkins, 1998:420-1.
22. Pifare R. New anticoagulants for the cardiovascular patient. Philadelphia: Hanley & Belfus, 1997.
23. Olshove VF, et al. Heparin dose response in pediatric cardiopulmonary bypass, J Extra Corpor Technol 1994;26:126-8.
24. Horkay F, Martin P, Walker D. Response to heparinzation in adults and children undergoing cardiac operations. Ann Thorac Surg 1992;53:822-6.
25. Cohen J, Rush BH. Heparin kinetics during paediatric open-heart operations. Perfusion 1986;1:271-5.
26. McKeage K, Plosker GL. Argatroban. Drugs 2001;61:515-22.
27. Bellinger DC, et al. Rapid cooling of infants on cardiopulmonary bypass adversely affects later cognitive function [abstract]. Circulation 1988;78:358.
28. Greeley W, et al. Effect of deep hypothermia and circulatory arrest on cerebreal blood flow, and metabolism. Ann Thorac Surg 1993;56:1464-6.
29. Greeley W, et al. The effect of hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral metabolism in neonates, infants, and children. J Thorac Cardiovasc Sur 1991;101:789-94.
30. Greeley W, et al. The effects of deep hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral blood flow in infants and children. J Thorac Cardiovasc Surg 1989;97:737-45.
31. Kirldin JK, Kirklin JW, Pacifico AD. Deep hypothermia and total circulatory arrest. In: Arcinegas E, ed. Pediatric cardiac surgery. Chicago: Year Book Medical Publishers, 1985.
32. Mezrow CK, et al. Metabolic correlates of neurologic and behavioral injury after prolonged hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1995;109:959-75.
33. Mezrow CK, et al. Cerebral effects of low-flow cardiopulmonary bypass and hypothermic circulatory arrest. Ann Thorac Surg 1994;57:532-9.
34. Skaryak LA, et al. Low flow cardiopulmonary bypass produces greater pulmonary dysfunction than circulatory arrest. Ann Thorac Surg 1996;62:1284-8.
35. Wernovsky G, et al, Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-35.
36. Langley S, et al. Intermittent perfusion protects the brain during deep hypothermic circulatory arrest. Ann Thorac Surg 1999;68:4-13.
37. Scheller MS, et al. A comparison of the effects on neuronal golgi morphology, assessed with electron microscopy, of cardiopulmonary bypass, low-flow bypass, and circulatory arrest during profound hypothermia. J Thorac Cardiovasc Surg 1992;1396-404.
38. Pearl JM, et al. Hyperoxia for managment of acid-base status during deep hypothermia with circulatory arrest. Ann Thorac Surg 2000;70:751-5.
39. Hindman BJ, et al. Brain blood flow and metabolism do not decrease at stable brain temperature during cardiopulmonary bypass in rabbits. Anesthesiology 1992;77:342-51.
40. Aoki M, et al. Effects of pH on brain energetics after hypothermic circulatory arrest. Ann Thorac Surg 1993;55:1093-103.
41. Jonas RA, et al. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J. Thorac Cardiovasc Surg 1993;106:362-8.
42. Skaryak LA, et al. Combining alpha-stat blood gas strategies during cooling prior to circulatory arrest provides optimal recovery of cerebral metabolism. American Heart Association 66th Scientific Sessions, Atlanta, Georgia, November 8-11, 1993.
43. Kirshborn PM, et al. Effect of aortopulmonary collaterals on cerebral cooling and metabolic recovery during cardiopulmonary bypass and circulatory arrest. Circulation 1995;92(Suppl II):II490-4.
44. Skaryak LA, et al. Modified ultrafiltrafion improves cerebral metabolic recovery after circulatory arrest. J Thorac Cardiovasc Surg 1995;109:744-52.
45. Mezrow CK, et al. A vunerable interval for cerebral injury: comparison of hypothermic circulatory arrest and low flow cardiopulmonary bypass. Cardiol Young 1993;3:287-98.
46. Daggett CW, et al. Modified ultrafiltration versus conventional ultrafiltration: a randomized prospective study in neonatal piglets. J Thorac Cardiovasc Surg 1998;115:336-42.
47. Eliott MJ. Ultrafiltrafion and modifed ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993;56:1518-22.
48. Sonntag J, et al. Complement and contact activation during cardiovascular operations in infants. Ann Thorac Surg 1998;65:525-31.
49. Wang MJ, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg 1996;61:651-6.
50. Journois D, et al. High-volume, zero-balance hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996;85:965-76.
51. Naik SK, Knight A, Elliott MJ. A prospective, randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991;84(Suppl III):III422-31.
52. Bando K, et al. Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Sur 1998;115:517-27.
53. Journois D, et al. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 1994;81:1181-9.
54. Koutlas TC, et al. Modified ultrafiltration reduces postoperative morbidity after cavopulmonary connection. Ann Thorac Surg 1997;64:37-43.
55. Meliones JN, et al. Modified ultrafiltrafion reduces airway pressures and improves lung compliance after congenital heart surgery [abstract]. J Am Coll Cardiol 1995;25:271.